HOME >> BIOLOGY >> NEWS
$7.3 million NIH grant establishes Wellstone Muscular Dystrophy Research Center at the UI

ellstone Center at the UI because we already have expertise, infrastructure and resources focused on muscular dystrophy, and our investigators have a long-standing record of success in translational research on muscular dystrophies and in providing advanced diagnostic services."

Muscular dystrophies are a diverse group of genetic diseases that cause progressive muscle wasting and weakness in affected individuals. The various types of muscular dystrophy differ in severity, age of onset, specific muscles affected and the rate at which symptoms progress. More than one million Americans have muscular dystrophy or a related neuromuscular disorder.

Campbell will lead an investigation on whether improving muscle membrane maintenance and repair can provide a basis for new treatments of Duchenne muscular dystrophy. Campbell previously identified important roles for two proteins called LARGE and dysferlin in muscle maintenance and repair. If the new studies show that increasing levels of either or both of the proteins produce a therapeutic effect, the UI team will look for ways, including pharmacological strategies, to modify the activity or expression of the proteins.

A second project, led by Katherine Mathews, M.D, UI associate professor of pediatrics and neurology, will concentrate on limb-girdle muscular dystrophy 2I (LGMD 2I). This form of muscular dystrophy is caused by mutations in Fukutin-related protein. However, different mutations in this one protein lead to widely varying clinical symptoms. The UI researchers will study the disease and its consequences in LGMD 2I patients and also will develop mouse models to learn more about the disease process and test potential treatments.

The third project, led by Baoli Yang, M.D., Ph.D., UI assistant professor of obstetrics and gynecology, will explore the possibility of using embryonic stem cells to treat muscular dystrophies. The researchers will work with mouse embryonic stem cells to disc
'"/>

Contact: Jennifer Brown
jennifer-l-brown@uiowa.edu
319-335-9917
University of Iowa
1-Jul-2005


Page: 1 2 3

Related biology news :

1. US Department of Defense awards $1.6 million for implantable biochip research
2. Nottingham biosciences million pound injection
3. $9 million EPSCoR grant to foster integrated research
4. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards
5. $125 million bioenergy initiative powered by Midwest ag industry, MSU research
6. UC Davis is partner in new $125 million federal bioenergy research center
7. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
8. The BBVA Foundation commits 2.4 million euros to research in Ecology and Conservation Biology
9. New $1.16 million study investigates how dietary iron is used by cells
10. 5.9 million award gives UK aging research a new lease on life
11. NIH awards nearly $21 million to fund cutting-edge research equipment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... June 04, 2020 , ... Greffex, a pioneering vaccine and gene therapy company ... “Neil understands the need for a global perspective to make an impact in a ... Bush will serve as an independent, director of the company. , “The Greffex board ...
(Date:5/28/2020)... ... ... CrucialTrak, a global designer and manufacturer of biometric access control systems, today announced ... sell its complete line of biometric readers and access gates . CEG is ... , Brett Mason, CrucialTrak’s Director of Channel Sales for the Americas is very ...
(Date:5/28/2020)... CHICAGO and FORT WORTH, Texas (PRWEB) , ... ... ... clinical stage biopharmaceutical company, announced today that interim results from their 1801 Phase ... Society of Clinical Oncology (ASCO) Annual Meeting which will take place virtually on ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ROCKY HILL, Conn. (PRWEB) , ... June 25, ... ... systems company formed to advance photodynamic therapy for treating cancer, today announced the ... Buffalo, New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System ... University of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness ...
(Date:6/23/2020)... ... 22, 2020 , ... Regen Suppliers, the one stop shop ... three, get the fourth unit free with no limit on the amniotic derived ... exosomes, have been a game changer for regenerative therapies. The products are manufactured ...
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis ... announced that it has filed an Investigational New Drug application (IND) with the ... of its lead drug candidate NBTX-001 in patients with panic disorder (PD). , ...
Breaking Biology Technology:
Cached News: